The UK government has launched a lawsuit claiming £220m ($351m) of damages against Servier Laboratories, alleging that the French pharmaceuticals company “abused” its dominant position by causing a delay to rivals that wanted to launch their own generic versions of a blood pressure drug.
Andrew Lansley, health secretary, and more than 150 primary care trusts are claiming that between July 2001 and July 2007, Servier formed and implemented a strategy of preventing the generic drug perindopril from reaching the market in a move that led to “elevated prices” being paid by the NHS.
via ft.com
No comments:
Post a Comment